GPC2 CAR T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GPC2 CAR T cells, covering 2025-12-29 to 2025-12-29. Get the full timeline:
Most recent: Clinical Trial Update: GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma [Phase 1]